HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krishnan Subbiah Selected Research

Neoplasms (Cancer)

3/2003Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas.
3/2003Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krishnan Subbiah Research Topics

Disease

2Lymphoma (Lymphomas)
03/2003 - 03/2003
2Neoplasms (Cancer)
03/2003 - 03/2003
2B-Cell Lymphoma (Lymphoma, B Cell)
03/2003 - 03/2003
1Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2003
1Burkitt Lymphoma (Burkitt's Lymphoma)
03/2003

Drug/Important Bio-Agent (IBA)

2AntibodiesIBA
03/2003 - 03/2003
1Biotin (Vitamin H)FDA Link
03/2003
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2003
1DOTA-biotin (90Y-DOTA-biotin)IBA
03/2003

Therapy/Procedure

2Radioimmunotherapy
03/2003 - 03/2003